Cas:27106-11-2 4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one manufacturer & supplier

We serve Chemical Name:4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one CAS:27106-11-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one

Chemical Name:4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one
CAS.NO:27106-11-2
Synonyms:4-butyl-5-thioxo-[1,2,4]triazolidin-3-one;4-butyl-5-mercapto-4H-1,2,4-triazol-3-ol;HMS1715P16
Molecular Formula:C6H11N3OS
Molecular Weight:173.23600
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:363ºC at 760mmHg
Density:1.29g/cm3
Index of Refraction:1.605
PSA:89.74000
Exact Mass:173.06200
LogP:1.07250

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4-butyl-5-thioxo-[1,2,4]triazolidin-3-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS1715P16 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-butyl-5-thioxo-[1,2,4]triazolidin-3-one Use and application,4-butyl-5-thioxo-[1,2,4]triazolidin-3-one technical grade,usp/ep/jp grade.


Related News: However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one manufacturer Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors. 4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one supplier Same as Imbruvica’s original monotherapy use, the Venclexta combo offers a convenient oral treatment, while the drug’s two other approved cocktails—with Gazyva or Roche’s Rituxan—involve infusions. 4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one vendor However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period. 4-butyl-5-sulfanylidene-1,2,4-triazolidin-3-one factory It wasn’t known if this was due to racial differences in breast cancer-related genetic mutations, making it unclear whether race should help guide genetic testing.